Literature DB >> 19239357

Regulatory T cell expansion and immune activation during untreated HIV type 1 infection are associated with disease progression.

Weiwei Cao1, Beth D Jamieson, Lance E Hultin, Patricia M Hultin, Roger Detels.   

Abstract

Regulatory T cells (Tregs) may play an important role in the immunopathology of chronic HIV-1 infection due to their potent suppressive activity of both T cell activation and effector function. To investigate the correlation between Tregs and immune activation during untreated chronic HIV-1 infection, we conducted a nested case-control study within the Multicenter AIDS Cohort Study (MACS). Twenty HIV-1-infected fast progressors (FP) and 40 slow progressors (SP) were included in our study using risk-set sampling. Nine age-matched HIV-1-uninfected men (UI) were also included. Cryopreserved peripheral blood mononuclear cells (PMBCs) were tested using flow cytometry analyses. We identified Tregs as Foxp3+CD25+CD4+ T cells and assessed the activation of CD4+ and CD8+ T cells by the expression of CD38, HLADR, or both markers simultaneously. There is a relative expansion of Tregs during HIV-1 infection, which is associated with disease progression. The increased CD38 expression on both CD4+ and CD8+ T cells expressed as either percentage or median fluorescence intensity (MFI) and the elevated proportion of CD8+ T cells that is HLADR+CD38+ were all associated with rapid HIV-1 progression. Counter to the assumed role of Tregs as the suppressors of activation, the expansion of Tregs was positively correlated with CD4+ T cell activation among HIV-1-infected fast progressors. The high level of Tregs associated with rapid HIV progression may suggest a detrimental role of these cells in the immune control of HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19239357      PMCID: PMC2782619          DOI: 10.1089/aid.2008.0140

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  48 in total

Review 1.  Regulatory T cells: key controllers of immunologic self-tolerance.

Authors:  S Sakaguchi
Journal:  Cell       Date:  2000-05-26       Impact factor: 41.582

Review 2.  Regulatory T cells in autoimmmunity*.

Authors:  E M Shevach
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

3.  Foxp3+ regulatory T cells in antiretroviral-naive HIV patients.

Authors:  Martin Montes; Dorothy E Lewis; Cesar Sanchez; Diego Lopez de Castilla; Edward A Graviss; Carlos Seas; Eduardo Gotuzzo; A Clinton White
Journal:  AIDS       Date:  2006-08-01       Impact factor: 4.177

4.  Simian immunodeficiency virus replicates to high levels in naturally infected African green monkeys without inducing immunologic or neurologic disease.

Authors:  S R Broussard; S I Staprans; R White; E M Whitehead; M B Feinberg; J S Allan
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

5.  CD4+CD25high regulatory cells in human peripheral blood.

Authors:  C Baecher-Allan; J A Brown; G J Freeman; D A Hafler
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

6.  The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3.

Authors:  C L Bennett; J Christie; F Ramsdell; M E Brunkow; P J Ferguson; L Whitesell; T E Kelly; F T Saulsbury; P F Chance; H D Ochs
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

7.  Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse.

Authors:  M E Brunkow; E W Jeffery; K A Hjerrild; B Paeper; L B Clark; S A Yasayko; J E Wilkinson; D Galas; S F Ziegler; F Ramsdell
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

8.  HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS.

Authors:  Jakob Nilsson; Adriano Boasso; Paula Andrea Velilla; Rui Zhang; Monica Vaccari; Genoveffa Franchini; Gene M Shearer; Jan Andersson; Claire Chougnet
Journal:  Blood       Date:  2006-08-10       Impact factor: 22.113

9.  X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy.

Authors:  R S Wildin; F Ramsdell; J Peake; F Faravelli; J L Casanova; N Buist; E Levy-Lahad; M Mazzella; O Goulet; L Perroni; F D Bricarelli; G Byrne; M McEuen; S Proll; M Appleby; M E Brunkow
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

10.  Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease.

Authors:  Katharina Lahl; Christoph Loddenkemper; Cathy Drouin; Jennifer Freyer; Jon Arnason; Gérard Eberl; Alf Hamann; Hermann Wagner; Jochen Huehn; Tim Sparwasser
Journal:  J Exp Med       Date:  2007-01-02       Impact factor: 14.307

View more
  48 in total

Review 1.  Biomarkers of immune dysfunction in HIV.

Authors:  Daniel E Nixon; Alan L Landay
Journal:  Curr Opin HIV AIDS       Date:  2010-11       Impact factor: 4.283

2.  Comprehensive analysis of frequency and phenotype of T regulatory cells in HIV infection: CD39 expression of FoxP3+ T regulatory cells correlates with progressive disease.

Authors:  Julian Schulze Zur Wiesch; Adriana Thomssen; Philip Hartjen; Ilona Tóth; Clara Lehmann; Dirk Meyer-Olson; Kristina Colberg; Sebastian Frerk; Dalia Babikir; Stefan Schmiedel; Olaf Degen; Stefan Mauss; Jürgen Rockstroh; Schlomo Staszewski; Pavel Khaykin; Alexander Strasak; Ansgar W Lohse; Gerd Fätkenheuer; Joachim Hauber; Jan van Lunzen
Journal:  J Virol       Date:  2010-11-03       Impact factor: 5.103

Review 3.  A coat of many colors: neuroimmune crosstalk in human immunodeficiency virus infection.

Authors:  Stephanie D Kraft-Terry; Shilpa J Buch; Howard S Fox; Howard E Gendelman
Journal:  Neuron       Date:  2009-10-15       Impact factor: 17.173

4.  Immunogenic and tolerogenic signatures in human immunodeficiency virus (HIV)-infected controllers compared with progressors and a conversion strategy of virus control.

Authors:  T Whittall; B Peters; D Rahman; C I Kingsley; R Vaughan; T Lehner
Journal:  Clin Exp Immunol       Date:  2011-11       Impact factor: 4.330

5.  Adenosine deaminase modulation of telomerase activity and replicative senescence in human CD8 T lymphocytes.

Authors:  Stanley T Parish; Sarah Kim; Rekha K Sekhon; Jennifer E Wu; Yukako Kawakatsu; Rita B Effros
Journal:  J Immunol       Date:  2010-02-10       Impact factor: 5.422

6.  Immune activation in the pathogenesis of treated chronic HIV disease: a workshop summary.

Authors:  Susan F Plaeger; Brenda S Collins; Runa Musib; Steven G Deeks; Sarah Read; Alan Embry
Journal:  AIDS Res Hum Retroviruses       Date:  2011-09-27       Impact factor: 2.205

7.  Early and long-lasting alteration of effector CD45RA(-)Foxp3(high) regulatory T-cell homeostasis during HIV infection.

Authors:  Federico Simonetta; Camille Lecuroux; Isabelle Girault; Cécile Goujard; Martine Sinet; Olivier Lambotte; Alain Venet; Christine Bourgeois
Journal:  J Infect Dis       Date:  2012-03-28       Impact factor: 5.226

8.  Phenotypic characterization of regulatory T cells from antiretroviral-naive HIV-1-infected people.

Authors:  Georgia N Ambada; Claudine E Ntsama; Nadesh N Nji; Loveline N Ngu; Carole N Sake; Abel Lissom; Flaurent T Tchouangeu; Jules Tchadji; Martin Sosso; François-Xavier Etoa; Godwin W Nchinda
Journal:  Immunology       Date:  2017-05-18       Impact factor: 7.397

9.  Regulatory T cell suppression of Gag-specific CD8 T cell polyfunctional response after therapeutic vaccination of HIV-1-infected patients on ART.

Authors:  Bernard J C Macatangay; Marta E Szajnik; Theresa L Whiteside; Sharon A Riddler; Charles R Rinaldo
Journal:  PLoS One       Date:  2010-03-24       Impact factor: 3.240

Review 10.  Role of the Fas/FasL pathway in HIV or SIV disease.

Authors:  Bhawna Poonia; C David Pauza; Maria S Salvato
Journal:  Retrovirology       Date:  2009-10-15       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.